Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hodgkin Disease | 4 | 2021 | 1429 | 0.970 |
Why?
|
| Immunoconjugates | 1 | 2023 | 279 | 0.710 |
Why?
|
| Telomere Shortening | 1 | 2019 | 56 | 0.660 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2023 | 387 | 0.660 |
Why?
|
| Telomerase | 1 | 2019 | 525 | 0.540 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2019 | 393 | 0.520 |
Why?
|
| Neutropenia | 1 | 2019 | 968 | 0.500 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 14289 | 0.180 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2022 | 128 | 0.180 |
Why?
|
| Adolescent | 7 | 2023 | 31252 | 0.180 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 15862 | 0.180 |
Why?
|
| Mutation | 1 | 2019 | 15179 | 0.170 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 184 | 0.170 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2021 | 366 | 0.160 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2021 | 502 | 0.140 |
Why?
|
| Radiation Pneumonitis | 1 | 2018 | 301 | 0.140 |
Why?
|
| Child | 6 | 2023 | 29154 | 0.140 |
Why?
|
| Sepsis | 1 | 2021 | 652 | 0.130 |
Why?
|
| Lymphoma, B-Cell | 1 | 2021 | 895 | 0.120 |
Why?
|
| Induction Chemotherapy | 1 | 2018 | 669 | 0.120 |
Why?
|
| Survivors | 1 | 2020 | 1031 | 0.120 |
Why?
|
| Stroke | 1 | 2022 | 1144 | 0.120 |
Why?
|
| Incidence | 2 | 2020 | 5673 | 0.110 |
Why?
|
| Cancer Survivors | 1 | 2019 | 650 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 4320 | 0.100 |
Why?
|
| Neoplasms, Second Primary | 1 | 2019 | 1350 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 14889 | 0.080 |
Why?
|
| Adult | 3 | 2023 | 77950 | 0.070 |
Why?
|
| Humans | 9 | 2023 | 261506 | 0.070 |
Why?
|
| Risk Factors | 2 | 2020 | 17523 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 10035 | 0.060 |
Why?
|
| Female | 5 | 2021 | 141928 | 0.060 |
Why?
|
| Prognosis | 1 | 2019 | 21713 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 182 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2021 | 263 | 0.040 |
Why?
|
| Immunity | 1 | 2021 | 342 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2021 | 436 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 561 | 0.040 |
Why?
|
| Male | 4 | 2021 | 123000 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2021 | 1144 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2021 | 966 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 1084 | 0.040 |
Why?
|
| Bleomycin | 1 | 2018 | 467 | 0.040 |
Why?
|
| SEER Program | 1 | 2019 | 1000 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2021 | 16273 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2021 | 1589 | 0.030 |
Why?
|
| Neoplasms | 1 | 2019 | 15193 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2018 | 2231 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 4744 | 0.030 |
Why?
|
| Young Adult | 2 | 2021 | 21445 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 4988 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 2738 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2018 | 3842 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 10001 | 0.020 |
Why?
|
| Lung | 1 | 2018 | 3151 | 0.020 |
Why?
|
| Infant | 1 | 2021 | 13310 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 7551 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 37905 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 86204 | 0.010 |
Why?
|